Ticker / small cap

AKTS

Aktis Oncology, Inc.
0
Contracts
$0
Total Value

Stock Metrics

12.3%
Short % Float
12.8d to cover · Moderate squeeze
75.1%
Inst % Float
10 holders · 2026-06-30
MPM Bioimpact LLC
Top Holder
9.1% of float
28.2M sh
Public Float
43/100
Dilution Score
Medium
Verified regulatory filings & proprietary analysis.

Fleet Intelligence

Dilution Risk
43/100
MEDIUM
Inst: 75.14% · Top: MPM Bioimpact LLC
Biotech Analytics
F
Oncology
14.61
Squeeze risk: MODERATEBiotech Grade: F

Biotech Analytics F Oncology · score 14.61

Insider Buying0
Publications100
Dilution Risk43
Clinical Trials8
Short Interest50